The modified surface treatment, from medical device company Tyber Medical, reduced Staphylococcus aureus, Pseudomonas aeruginosa and antibiotic-resistant E. coli without the use of pharmacological agents, according to the research.
“We have shown, for the first time, that nano-scale surface features alone can reduce implant infection without resorting to the use of antibiotics, which has clearly been shown over the past decade to be a failed attempt to eradicate implant infections,” said Thomas Webster, PhD, principal investigator. “Our research has shown that this versatile surface treatment process alters surface energy to eliminate gram negative, gram positive and even antibiotic-resistant bacteria while promoting bone cell functions.”
More articles on surgical infections:
Study examines risk of CRE colonization becoming an infection: 3 findings
Pulsed xenon UV reduces SSIs, saves potentially $500k at community hospital
Top 10 sentinel events in 2015
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.